Erythromycin estolate; sulfisoxazole acetyl - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for erythromycin estolate; sulfisoxazole acetyl and what is the scope of patent protection?
Erythromycin estolate; sulfisoxazole acetyl
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for erythromycin estolate; sulfisoxazole acetyl
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | erythromycin estolate; sulfisoxazole acetyl at DailyMed |
US Patents and Regulatory Information for erythromycin estolate; sulfisoxazole acetyl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | ILOSONE SULFA | erythromycin estolate; sulfisoxazole acetyl | SUSPENSION;ORAL | 050599-001 | Sep 29, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |